InvestSMART

333D Limited (ASX:T3D)

ALERT: Price-sensitive ASX Announcement for T3D
Current share price for T3D : $0.027 -0.019 (-41.30%)+
Announcement
Release
30 Jan 2026 3:27PM
Price at Release
$0.046
Full Release
download
Summary
333D Limited released its Quarterly Activities/Appendix 4C Cash Flow Report for the quarter ending 31 December 2025. The report indicates that the company continues to focus on digital asset management services, generating $330,917 in cash receipts from customers. Operating cash used was $99,180, an improvement from the previous quarter. The company maintains a cash balance of $736,328, with an additional Bitcoin valuation of AUD$257,363, culminating in total cash and cash equivalents of $993,691. Expenses included service and operating costs, staff costs, and administration totaling approximately $430,097. Payments to related parties amounted to $113,351. During the quarter, the company also expanded its operations in the preventative healthcare market by partnering with BioScan 360, showcasing its strategic investment in Blockchain technology for secure data management.
Key Points
  • 333D Limited focuses on digital asset management in healthcare.
  • Cash receipts from customers were $330,917 this quarter.
  • Net operating cash used was $99,180 during the quarter.
  • Total cash and cash equivalents were $993,691, including Bitcoin holdings.
  • Expenses totaled approximately $430,097 for the quarter.
  • Payments to related parties amounted to $113,351.
  • 333D partnered with BioScan 360 for healthcare market expansion.
  • Investments in Blockchain technology enhance data management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.